Delivery Order SPE2DB24D3014-SPE2DB25FKULV
Award Date 8/26/25
Potential Completion Date 8/27/25
Potential Value $2.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,783.60 on May 13, 2025, for the supply of Vyvanse 40 mg capsules (100-count units) by the Defense Logistics Agency. This contract utilizes firm fixed pricing under a non-set-aside, competitively awarded arrangement with an ultimate completion date of May 14, 2025. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,904.90 by the Defense Logistics Agency's Medical Supply Chain on August 12, 2025, for the supply of Vyvanse 30 milligram capsules (100 count). The contract represents a firm fixed-price delivery order with an ultimate completion date of August 13, 2025, and was competitively awarded without set-aside designation. This award falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Vyvanse 30 mg capsules (100-count) with a contract value of $2,117.56 and completion date of July 30, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $5,884.22 by the Defense Logistics Agency (DLA) on August 15, 2025, for the supply of Vyvanse 20 mg capsules (100-count units). The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance is scheduled for completion by August 18, 2025, with fulfillment from the contractor's corporate office located in Conshohocken, Pennsylvania. This delivery order is...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on October 6, 2025, for the supply of Vyvanse capsules (20 mg) valued at $3,108.21. This firm fixed-price contract, which is set to be completed by October 7, 2025, supports the Medical Supply Chain division of the Defense Logistics Agency. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency on August 29, 2025, for the supply of Vyvanse 60 mg capsules (100-count units). The contract was competitively awarded without set-aside designation and carries a ceiling value of $1,065.93, with a firm fixed price structure and an ultimate completion date of September 2, 2025. This delivery order is issued under...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency on August 19, 2025, for the supply of Vyvanse 50 mg capsules (100-count units) with a ceiling value of $1,193.76. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 20, 2025, and performance will be executed from the vendor's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation. This...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 19, 2025, for the supply of Vyvanse 40 mg capsules in a quantity of 100 units. The contract is valued at $2,255.82 with a firm fixed price structure and a completion date of August 20, 2025. This non-set-aside award represents a routine pharmaceutical procurement through the DLA's medical supply chain, with performance to be executed from the contractor's corporate headquarters location in...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a $6,108.12 delivery order by the Defense Logistics Agency (DLA) on September 3, 2025, for the supply of Vyvanse 10 mg capsules (100-count units). This firm fixed-price, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Vyvanse 30 mg capsules (100 count) with a ceiling value of $2,380.10. This competitively awarded, non-set-aside firm fixed price delivery order is scheduled for completion by August 12, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The order represents a continuation of AmerisourceBergen's role as a critical...